T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple β-cell autoantibodies

Journal of Autoimmunity

Volumn 31, Issue 2, 2008, Pages 142-148

  Marttila, Jane ^a   Huttunen, Suvi ^a   Vaarala, Outi ^b   Suzuki, Kunimasa ^c   Elliott, John F ^c   Närvänen, Ale ^d   Knip, Mikael ^e,f   Simell, Olli ^a   Ilonen, Jorma ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autoantigen; Insulin; T cell; T cell epitope; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIBODY; B1 PEPTIDE; B2 PEPTIDE; B3 PEPTIDE; B8 PEPTIDE; B9-13 PEPTIDE; BOVINE INSULIN; H1 PEPTIDE; H2 PEPTIDE; H3 PEPTIDE; H8 PEPTIDE; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; HUMAN INSULIN; INSULIN; IP12 PEPTIDE; PEPTIDES AND PROTEINS; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CHILD; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; AGE FACTORS; ANIMALS; AUTOANTIBODIES; CATTLE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INSULIN; INSULIN-SECRETING CELLS; LYMPHOCYTE ACTIVATION; PEPTIDES; REFERENCE STANDARDS; T-LYMPHOCYTES;

EID: 50549103960     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.024     Document Type: Article

References (23)

1. Ziegler A., Hummel M., Schenker M., and Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes - the 2-year analysis of the German BABYDIAB study. Diabetes 48 (1999) 460-468
2. Kukko M., Kimpimäki T., Korhonen S., Kupila A., Simell S., Veijola R., et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 90 (2005) 2712-2717
3. Arslanian S.A., Becker D.J., Rabin B., Atchison R., Eberhardt M., Cavender D., et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34 (1985) 926-933
4. Schloot N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Wang T., et al. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabeteic patients and healthy control subjects. Diabetologia 40 (1997) 564-572
5. Ellis T., Jodoin E., Ottendorfer E., Salisbury P., She J.-X., Schartz D., et al. Cellular immune responses against proinsulin - no evidence for enhanced reactivity in individuals with IDDM. Diabetes 48 (1999) 299-303
6. Durinovic-Belló I., Schlosser M., Riedl M., Maisel N., Rosinger S., Kalbacher H., et al. Pro-and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 type 1 diabetes. Diabetologia 47 (2004) 439-450
7. Alleva D.G., Crowe P.D., Jin L., Kwok W.W., Ling N., Gottschalk M., et al. A disease-associated cellular immune response in type 1 diabetetics to an immunodominant epitope of insulin. J Clin Invest 107 (2001) 173-180
8. Abiru N., Maniatis A.K., Yu L., Miao D., Moriyama H., Wegmann D., et al. Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. Diabetes 50 (2001) 1274-1281
9. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435 (2005) 220-223
10. Rudy G., Stone N., Harrison L.C., Colman P.G., Mcnair P., Brusic V., et al. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1 (1995) 625-633
11. Öling V., Marttila J., Ilonen J., Nepon G., Knip M., Simell O., et al. GAD65- and proinsulin-specific CD4+T cells detected by MHC class II tetramers in peripheral blood of type I diabetes patients and at-risk subjects. J Autoimmun 25 (2005) 235-243
12. Higashide T., Kawamura T., Nagata M., Kotani R., Kimura K., Hirose M., et al. T cell epitope mapping study with insulin overlapping peptides using ELISPOT assay in Japanese children and adolescents with type 1 diabetes. Pediatr Res 59 (2006) 445-450
13. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435 (2005) 224-228
14. Mannering S.I., Harrison L.C., Williamson N.A., Morris J.S., Thearle D.J., Jensen K.P., et al. The insulin A-chain epitope recognized by human T cells in posttranslationally modified. J Exp Med 202 (2005) 1191-1197
15. Vaarala O., Paronen J., Otonkoski T., and Åkerblom H.K. Cow milk feeding induces antibodies in children - a link between cow milk a insulin-dependent diabetes mellitus?. Scand J Immunol 47 (1998) 131-135
16. Vaarala O., Knip M., Paronen J., Hämäläinen A.M., Muona P., Väätäinen M., et al. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 48 (1999) 1389-1394
17. Paronen J., Knip M., Savilahti E., Virtanen S.M., Ilonen J., Åkerblom H.K., et al. the Finnish Trial to reduce IDDM in the genetically at risk study group: Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Diabetes 49 (2000) 1657-1665
18. Vaarala O. The gut system and type 1 diabetes. Ann N Y Acad Sci 958 (2002) 39-46
19. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A.M., et al. Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland: feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44 (2001) 290-297
20. Kupila A., Sipilä J., Keskinen P., Simell T., Knip M., Pulkki K., et al. Intranasally administered insulin intended for prevention of type 1 diabetes - a safety study in healthy adults. Diabetes Metab Res Rev 19 (2003) 415-420
21. Näntö-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, et al. Intranasally administered insulin intended for prevention of type 1 diabetes - a safety study in healthy adults, Submitted for publication.
22. Hermann R., Turpeinen H., Laine A.-P., Veijola R., Knip M., Simell O., et al. HLA-DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62 (2003) 162-169
23. Naik R.G., Beckers C., Wentwoord R., Frenken A., Duinkerken G., Brooks-Worrell B., et al. Precursor frequencies of T cells reactive to insulin on recent onset type 1 diabetes mellitus. J Autoimmun 23 (2004) 55-61